Birmingham Quality POCT Suite
[Birmingham Quality POCT Suite]
EPTIS factsheet 1615706 | Last revision 2026-09-24 | URL: https://www.eptis.bam.de/pts1615706 https://www.eptis.bam.de/pts1615706
| PT provider | ||||||||||||||||||||||||||||
| PT provider | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | |||||||||||||||||||||||||||
| Based in | United Kingdom | |||||||||||||||||||||||||||
| Language(s) | English | |||||||||||||||||||||||||||
| Remarks | This suite allows a range of analytes and a range of frequency options tailored to your specific needs. Operating as a Hub-and-Spoke, not only do individual end users receive an easy to understand report, but the Hub coordinator receives a range of reports and spreadsheets for them to efficiently run their own service in the way they want. Provides EQA coverage for a range of analytes for which Point of Care Testing is commonly performed in a variety of settings, including hospital settings and community settings such as GP surgeries, pharmacies and gyms. Analytes include HbA1c and Lipids which are part of the NHS Health Checks programme for Diabetes and Cardiovascular Risk assessment, and Creatinine. HbA1c is also often performed as POC test in Diabetes clinics and by Diabetic home care teams. Creatinine is often analysed by POC devices to assess renal function in the clinic setting, especially in radiology (before contrast administration), and oncology (before chemotherapy treatment). Material is Whole Blood for all schemes, as patient testing is often performed on finger prick capillary samples. The scheme also allows hub coordinators to monitor performance of devices across all locations. | |||||||||||||||||||||||||||
| Keywords | ||||||||||||||||||||||||||||
| Product groups |
Health care / medical devices
|
|||||||||||||||||||||||||||
| Testing fields |
Medical analysis
|
|||||||||||||||||||||||||||
| Technical details | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Aims of the PT scheme | ||||||||||||||||||||||||||||
| Target group of participants | Clinical Chemistry Public & Private Labs | |||||||||||||||||||||||||||
| Linked to specific legislation / standards | ISO/IEC 17043:2023 | |||||||||||||||||||||||||||
| Additional, subsidiary aims | Post market surveillance of testing methods | |||||||||||||||||||||||||||
| Number of participants | ||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043:2023 |
|||||||||||||||||||||||||||
| Operation is commissioned / requested by | ||||||||||||||||||||||||||||
| Fees and frequency | ||||||||||||||||||||||||||||
| Participation fee | Contact provider for current fee, which depends on location and extent of service required. | |||||||||||||||||||||||||||
| Regularly operated | Yes (Various) | |||||||||||||||||||||||||||
| Year of first operation | 2020 | |||||||||||||||||||||||||||
| Contact details of the PT provider | ||||||||||||||||||||||||||||
| Provider | Contact person | |||||||||||||||||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Phone: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Phone: +44 121 414 7300 Fax: Email: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
|||||||||||||||||||||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.